Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Theoretical Framework for Retrospective Studies of the Effectiveness of SARS-CoV-2 Vaccines
Joseph A. Lewnard, Manish M. Patel, Nicholas P. Jewell, et al.
Epidemiology (2021) Vol. 32, Iss. 4, pp. 508-517
Open Access | Times Cited: 100

Showing 1-25 of 100 citing articles:

Association Between mRNA Vaccination and COVID-19 Hospitalization and Disease Severity
Mark W. Tenforde, Wesley H. Self, Katherine Adams, et al.
JAMA (2021) Vol. 326, Iss. 20, pp. 2043-2043
Open Access | Times Cited: 586
Clinical severity of, and effectiveness of mRNA vaccines against, covid-19 from omicron, delta, and alpha SARS-CoV-2 variants in the United States: prospective observational study
Adam S. Lauring, Mark W. Tenforde, James D. Chappell, et al.
BMJ (2022), pp. e069761-e069761
Open Access | Times Cited: 581
Effect of Delta variant on viral burden and vaccine effectiveness against new SARS-CoV-2 infections in the UK
Koen B. Pouwels, Emma Pritchard, Philippa C. Matthews, et al.
Nature Medicine (2021) Vol. 27, Iss. 12, pp. 2127-2135
Open Access | Times Cited: 533
Effectiveness of mRNA-1273 against SARS-CoV-2 Omicron and Delta variants
Hung Fu Tseng, Bradley K. Ackerson, Yi Luo, et al.
Nature Medicine (2022) Vol. 28, Iss. 5, pp. 1063-1071
Open Access | Times Cited: 492
Effect of Covid-19 Vaccination on Transmission of Alpha and Delta Variants
David W. Eyre, Donald Taylor, M. B. Purver, et al.
New England Journal of Medicine (2022) Vol. 386, Iss. 8, pp. 744-756
Open Access | Times Cited: 439
Effectiveness of the CoronaVac vaccine in older adults during a gamma variant associated epidemic of covid-19 in Brazil: test negative case-control study
Otávio T. Ranzani, Matt D. T. Hitchings, Murilo Dorión, et al.
BMJ (2021), pp. n2015-n2015
Open Access | Times Cited: 278
SARS-CoV-2 reinfections: Overview of efficacy and duration of natural and hybrid immunity
Stefan Pilz, Verena Theiler‐Schwetz, Christian Trummer, et al.
Environmental Research (2022) Vol. 209, pp. 112911-112911
Open Access | Times Cited: 233
Effectiveness of mRNA-1273 against delta, mu, and other emerging variants of SARS-CoV-2: test negative case-control study
Katia Bruxvoort, Lina S. Sy, Lei Qian, et al.
BMJ (2021), pp. e068848-e068848
Open Access | Times Cited: 221
Effectiveness of Face Mask or Respirator Use in Indoor Public Settings for Prevention of SARS-CoV-2 Infection — California, February–December 2021
Kristin L. Andrejko, Jake M. Pry, Jennifer F. Myers, et al.
MMWR Morbidity and Mortality Weekly Report (2022) Vol. 71, Iss. 6, pp. 212-216
Open Access | Times Cited: 172
Effectiveness of CoronaVac among healthcare workers in the setting of high SARS-CoV-2 Gamma variant transmission in Manaus, Brazil: A test-negative case-control study
Matt D. T. Hitchings, Otávio T. Ranzani, Mario Torres, et al.
The Lancet Regional Health - Americas (2021) Vol. 1, pp. 100025-100025
Open Access | Times Cited: 160
Covid-19 Vaccine Effectiveness and the Test-Negative Design
Natalie E. Dean, Joseph W. Hogan, Mireille E. Schnitzer
New England Journal of Medicine (2021) Vol. 385, Iss. 15, pp. 1431-1433
Open Access | Times Cited: 155
The effectiveness of COVID-19 vaccines in reducing the incidence, hospitalization, and mortality from COVID-19: A systematic review and meta-analysis
Kazem Rahmani, Rasoul Shavaleh, Mahtab Forouhi, et al.
Frontiers in Public Health (2022) Vol. 10
Open Access | Times Cited: 151
Effectiveness of Severe Acute Respiratory Syndrome Coronavirus 2 Messenger RNA Vaccines for Preventing Coronavirus Disease 2019 Hospitalizations in the United States
Mark W. Tenforde, Manish M. Patel, Adit A. Ginde, et al.
Clinical Infectious Diseases (2021) Vol. 74, Iss. 9, pp. 1515-1524
Open Access | Times Cited: 145
Odds of Testing Positive for SARS-CoV-2 Following Receipt of 3 vs 2 Doses of the BNT162b2 mRNA Vaccine
Tal Patalon, Sivan Gazit, Virginia E. Pitzer, et al.
JAMA Internal Medicine (2021) Vol. 182, Iss. 2, pp. 179-179
Open Access | Times Cited: 144
Impact of Delta on viral burden and vaccine effectiveness against new SARS-CoV-2 infections in the UK
Koen B. Pouwels, Emma Pritchard, Philippa C. Matthews, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 141
Effectiveness of CoronaVac, ChAdOx1 nCoV-19, BNT162b2, and Ad26.COV2.S among individuals with previous SARS-CoV-2 infection in Brazil: a test-negative, case-control study
Thiago Cerqueira‐Silva, Jason R. Andrews, Viviane Boaventura, et al.
The Lancet Infectious Diseases (2022) Vol. 22, Iss. 6, pp. 791-801
Open Access | Times Cited: 120
Effectiveness of BNT162b2 Vaccine against Critical Covid-19 in Adolescents
Samantha M. Olson, Margaret M. Newhams, Natasha Halasa, et al.
New England Journal of Medicine (2022) Vol. 386, Iss. 8, pp. 713-723
Open Access | Times Cited: 104
Effectiveness of an inactivated Covid-19 vaccine with homologous and heterologous boosters against Omicron in Brazil
Otávio T. Ranzani, Matt D. T. Hitchings, Rosana Leite de Melo, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 87
Effectiveness of nirmatrelvir–ritonavir in preventing hospital admissions and deaths in people with COVID-19: a cohort study in a large US health-care system
Joseph A. Lewnard, John M. McLaughlin, Deborah E. Malden, et al.
The Lancet Infectious Diseases (2023) Vol. 23, Iss. 7, pp. 806-815
Open Access | Times Cited: 86
The Biological Functions and Clinical Significance of SARS-CoV-2 Variants of Corcern
Hikmet Akkız
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 82
Nirsevimab Effectiveness Against Cases of Respiratory Syncytial Virus Bronchiolitis Hospitalised in Paediatric Intensive Care Units in France, September 2023–January 2024
Juliette Paireau, C. Durand, S. Raimbault, et al.
Influenza and Other Respiratory Viruses (2024) Vol. 18, Iss. 6
Open Access | Times Cited: 25
The impact of SARS-CoV-2 vaccination on Alpha and Delta variant transmission
David W. Eyre, Donald Taylor, M. B. Purver, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 97
Effectiveness of SARS-CoV-2 mRNA Vaccines for Preventing Covid-19 Hospitalizations in the United States
Mark W. Tenforde, Manish M. Patel, Adit A. Ginde, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 91
Effectiveness of COVID-19 vaccines in preventing SARS-CoV-2 infection and hospitalisation, Navarre, Spain, January to April 2021
Iván Martínez‐Baz, Ana Miqueleiz, Itziar Casado, et al.
Eurosurveillance (2021) Vol. 26, Iss. 21
Open Access | Times Cited: 79
Effectiveness of ChAdOx1 vaccine in older adults during SARS-CoV-2 Gamma variant circulation in São Paulo
Matt D. T. Hitchings, Otávio T. Ranzani, Murilo Dorión, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 71
Page 1 - Next Page

Scroll to top